UST Completes Strategic Transaction with Bain Capital

Sep 4, 2025
UST has finalized a strategic transaction with Bain Capital involving its subsidiary UST HealthProof, as announced in a press release. This move aligns UST's focus on high-growth areas like enterprise AI and cloud transformation.

UST has finalized a strategic transaction with Bain Capital involving its subsidiary UST HealthProof, announced in a press release. This transaction will see UST HealthProof combine with HealthEdge, creating a leading platform for healthcare payers.

The divestment allows UST to concentrate on high-growth sectors such as enterprise AI, cloud transformation, data modernization, and platform engineering. These areas are pivotal in reshaping digital futures across various industries, including healthcare, BFSI, and retail.

Meanwhile, UST HealthProof, with the backing of Bain Capital Ventures, is set to scale rapidly and explore new partnerships. This strategic move is part of UST's broader growth strategy, ensuring continued innovation and value creation for its clients and employees worldwide.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

AI Funding Brief

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.